Supplemental New Drug Application for at-home Igalmi aims to provide a self-administered option for agitation in schizophrenia and bipolar disorder.
Brimonidine Tartrate 0.15%, ophthalmic solution, is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results